Literature DB >> 21454808

Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteries.

Bo Jiang1, Kun Qian, Liang Du, Ian Luttrell, Kanchan Chitaley, David A Dichek.   

Abstract

OBJECTIVE: Vascular gene transfer is a powerful tool for investigating and treating vascular diseases; however, its utility is limited by brevity of transgene expression and vector-associated inflammation. Helper-dependent adenovirus (HDAd), an advanced-generation adenovirus that lacks all viral genes, is superior to first-generation adenovirus (FGAd) in normal rabbit arteries. We compared HDAd to FGAd in arteries of cholesterol-fed rabbits, a model of early atherogenesis in which transgene expression might be decreased, and inflammation increased. METHODS AND
RESULTS: Carotid arteries of chow- and cholesterol-fed rabbits were infused with FGAd, HDAd, or medium. HDAd expressed a transgene at least as well in arteries of cholesterol-fed rabbits as in arteries of chow-fed rabbits and expressed more durably than FGAd. In arteries of cholesterol-fed rabbits, HDAd stimulated less intimal growth, lipid deposition, and inflammation than FGAd. Neither vector affected phenylephrine-induced contraction or nitroprusside-mediated relaxation; however, both vectors decreased maximal acetylcholine-stimulated vasorelaxation. The relative absence of intimal growth in HDAd arteries could interfere with the utility of this model for testing atheroprotective genes; however, both coinfusion of FGAd and extension of cholesterol feeding yielded larger intimal lesions, on which atheroprotective genes could be tested.
CONCLUSION: HDAd is superior to FGAd for expression of transgenes in atherosclerosis-prone arteries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454808      PMCID: PMC3098319          DOI: 10.1161/ATVBAHA.111.225516

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

1.  Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.

Authors:  Marcin Gruchała; Shalini Bhardwaj; Katri Pajusola; Himadri Roy; Tuomas T Rissanen; Ilze Kokina; Ivana Kholová; Johanna E Markkanen; Juha Rutanen; Tommi Heikura; Kari Alitalo; Hansruedi Büeler; Seppo Ylä-Herttuala
Journal:  J Gene Med       Date:  2004-05       Impact factor: 4.565

2.  A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.

Authors:  G Vassalli; R Agah; R Qiao; C Aguilar; D A Dichek
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

3.  Helper-dependent adenoviral vector achieves prolonged, stable expression of interleukin-10 in rabbit carotid arteries but does not limit early atherogenesis.

Authors:  Liang Du; Nagadhara Dronadula; Shinji Tanaka; David A Dichek
Journal:  Hum Gene Ther       Date:  2011-04-11       Impact factor: 5.695

4.  Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation.

Authors:  D B Schneider; G Vassalli; S Wen; R M Driscoll; A B Sassani; M B DeYoung; R Linnemann; R Virmani; D A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

Review 5.  Cardiovascular gene therapy.

Authors:  S Ylä-Herttuala; J F Martin
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

6.  In vivo gene transfer of endothelial nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits enhances endothelium-dependent relaxations.

Authors:  J Sato; T Mohácsi; A Noel; C Jost; P Gloviczki; G Mozes; Z S Katusic; T O'Brien; W G Mayhan
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

7.  Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.

Authors:  H S Qian; K Channon; V Neplioueva; Q Wang; M Finer; L Tsui; S E George; J McArthur
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

Review 8.  Development and use of gene transfer for treatment of cardiovascular disease.

Authors:  Andrew H Baker
Journal:  J Card Surg       Date:  2002 Nov-Dec       Impact factor: 1.620

9.  Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth.

Authors:  Marten Falkenberg; Clifford Tom; Mary Beth DeYoung; Shan Wen; Ruth Linnemann; David A Dichek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

10.  Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.

Authors:  Aaron E Cozen; Hideaki Moriwaki; Michal Kremen; Mary Beth DeYoung; Helén L Dichek; Katherine I Slezicki; Stephen G Young; Murielle Véniant; David A Dichek
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

View more
  12 in total

1.  Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

Authors:  Erica L Sanchez; Thomas H Pulliam; Terri A Dimaio; Angel B Thalhofer; Tracie Delgado; Michael Lagunoff
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits.

Authors:  Bradley K Wacker; Nagadhara Dronadula; Lianxiang Bi; Alexis Stamatikos; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-09       Impact factor: 8.311

3.  Exosome-Mediated Transfer of Anti-miR-33a-5p from Transduced Endothelial Cells Enhances Macrophage and Vascular Smooth Muscle Cell Cholesterol Efflux.

Authors:  Alexis Stamatikos; Ethan Knight; Lucia Vojtech; Lianxiang Bi; Bradley K Wacker; Chongren Tang; David A Dichek
Journal:  Hum Gene Ther       Date:  2020-01-16       Impact factor: 5.695

4.  Stable In Vivo Transgene Expression in Endothelial Cells with Helper-Dependent Adenovirus: Roles of Promoter and Interleukin-10.

Authors:  Nagadhara Dronadula; Bradley K Wacker; Reginald Van Der Kwast; Jingwan Zhang; David A Dichek
Journal:  Hum Gene Ther       Date:  2016-11-14       Impact factor: 5.695

5.  Efficient gene transfer and durable transgene expression in grafted rabbit veins.

Authors:  Liang Du; Jingwan Zhang; Alexander W Clowes; David A Dichek
Journal:  Hum Gene Ther       Date:  2015-01       Impact factor: 5.695

6.  In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium.

Authors:  Bradley K Wacker; Lianxiang Bi; David A Dichek
Journal:  J Vis Exp       Date:  2018-05-06       Impact factor: 1.355

7.  Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis.

Authors:  Rowan Flynn; Kun Qian; Chongren Tang; Nagadhara Dronadula; Joshua M Buckler; Bo Jiang; Shan Wen; Helén L Dichek; David A Dichek
Journal:  Mol Ther       Date:  2011-07-19       Impact factor: 11.454

8.  Improved animal models for testing gene therapy for atherosclerosis.

Authors:  Liang Du; Jingwan Zhang; Guido R Y De Meyer; Rowan Flynn; David A Dichek
Journal:  Hum Gene Ther Methods       Date:  2014-02-14       Impact factor: 2.396

9.  Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.

Authors:  Bo Jiang; Liang Du; Rowan Flynn; Nagadhara Dronadula; Jingwan Zhang; Francis Kim; David Dichek
Journal:  Hum Gene Ther       Date:  2012-09-24       Impact factor: 5.695

Review 10.  Targeting sarcoplasmic reticulum calcium ATPase by gene therapy.

Authors:  Judith K Gwathmey; Armen Yerevanian; Roger J Hajjar
Journal:  Hum Gene Ther       Date:  2013-11       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.